Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07352306 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Topical Diacerein in Psoriasis Vulgaris

Study acronym: DIA
StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Cairo University
1,562 trials monitored
See 18 trials at risk
Psoriasis
591 trials monitored
See 24 trials at risk
The goal of this clinical trial is to evaluate the safety and effectiveness of topical diacerein in adults with psoriasis vulgaris. The primary objective of the study is to compare the proportion of participants who achieve a clinically meaningful improvement in disease severity between the topical diacerein group and the placebo group. Participants will: Be assigned to receive topical diacerein 1% or placebo twice daily for a treatment period of 2 months. Attend follow-up visits at Weeks 2, 4, 6, and 8. Undergo an additional evaluation one month after treatment cessation.
Trial Details
NCT Number NCT07352306
Lead Sponsor Cairo University
Conditions
(from sponsor)		 Psoriasis Vulgaris
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov